Clinical Trial Update: Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety of two doses of Avaxim 80U Pediatric (inactivated Hepatitis A vaccine) in toddlers, children, and adolescents.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Avaxim 80U Pediatric (Hepatitis A vaccine, inactivated)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Hepatitis A, Hepatitis A Virus | Phase 4 | Status: COMPLETED